Drug Safety Expected To Be Only Addition To PDUFA Reauthorization In House
This article was originally published in The Pink Sheet Daily
Executive Summary
House Commerce Committee leaders aim to ready user fee, pediatric pharmaceutical program reauthorization measures for floor action around Fourth of July.